ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

Quarterly net revenues of $237.5 million, an increase of 20.5% year-over-yearPurified Cortrophin® Gel net revenues of $75.1 million, an increase ...
Seeking Alpha

Oceaneering International: Optimistic On Accelerated Business Activities In Defense And Energy

Oceaneering International is rated a 'Buy', with a 13% upside driven by robust defense demand and service-based contract focus. ADTech segment revenues surged 35% YoY, now comprising nearly 20% of OII ...

ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

Quarterly net revenues of $237.5 million, an increase of 20.5% year-over-yearPurified Cortrophin- Gel net revenues of $75.1 million, an increase of 42.1% year-over-yearQuarterly GAAP net income availa ...